<DOC>
	<DOCNO>NCT01351272</DOCNO>
	<brief_summary>In study investigator measure functional brain activity adult Attention Deficit Hyperactivity Disorder ( ADHD ) patient , genotyped accord COMT genotype , Working Memory Paradigm , placebo control treatment MPH 6 WEEKS . Within design , investigator able evaluate therapeutic effect MPH treatment cognitive function .</brief_summary>
	<brief_title>Genetic Modulation Working Memory Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Only participant include ( 1 ) fulfil diagnostic criterion define guideline diagnosis ADHD childhood adulthood ( 2 ) would treat MPH also clinical indication outside study . Provision write informed consent A diagnosis ADHD ( 314.xx ) Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) Females male age 1850 year Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment Able understand comply requirement study Righthanded accord Edinburgh Handedness Inventory ( Oldfield , 1971 ) German first language Caucasian ethnicity Pregnancy lactation ; woman capable childbearing require use reliable method ( Pearlindex &lt; 1 % ) contraception ( e.g . hormonal treatment , intrauterine device , vasoligature partner , sexual abstinent ) Any current DSMIV Axis I disorder define inclusion criterion require current additional treatment Motoric tic , sibling tic positive family history diagnosis Tourette syndrome Patients , opinion investigator , pose imminent risk suicide danger self others Known intolerance lack response methylphenidate , judge investigator Present pretreatment methylphenidate ( within last three month prior study treatment ) Intake MAOinhibitors within last 14 day prior study treatment Medical condition would affect absorption , distribution , metabolism , excretion study treatment Unstable inadequately treat medical illness ( e.g . Congestive Heart Failure / CHF , angina pectoris , hypertension , narrow angle glaucoma , hyperthyreoidism , thyreotoxicosis , cardiac arrhythmia , cardiac infarction ) judge investigator . Epilepsy An absolute neutrophil count ( ANC ) minor 1.5 x 10 exp 9 per litre Involvement plan conduct study Previous enrolment randomisation treatment present study Participation another drug trial within 4 week prior enrolment study Moderate , severe , profound mental retardation Heart pacemaker , cochlea implant , metal part head outside mouth</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>